dCas9-mediated transcriptional activation of tissue inhibitor of metalloproteinases

References

• Hu J, Van den Steen PE, Sang QX, Opdenakker G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov. 2007;6(6):480–498.
   PubMed Web of Science ®Google Scholar
• Mohan V, Talmi-Frank D, Arkadash V, Papo Niv, Sagi I. Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine. Metalloprot Medicine. 2016;3:31–47.
   Google Scholar
• Brkic M, Lalusu S, Libert C, Vandenbroucke RE. Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases. Mediators Inflam. 2015;2015:620581.
   PubMed Web of Science ®Google Scholar
• Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nature Rev Immunol. 2013;13:649–665.
   PubMed Web of Science ®Google Scholar
• Vafadari B, Salamian A, Kaczmarek L. MMP-9 in translation: from molecule to brain physiology, pathology, and therapy. J Neurochem. 2016;Suppl 2:91–114.
   Google Scholar
• Wright JW, Harding JW. Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction. Neural Plast. 2009;2009:579382.
   PubMed Web of Science ®Google Scholar
• Vandooren J, Van den Steen PE, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol Biol. 2013;48(3):222–272.
   PubMed Web of Science ®Google Scholar
• Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophy Acta. 2010;1803(1):55–71.
   PubMed Web of Science ®Google Scholar
• Cheng AW, Wang H, Yang H, et al. Multiplexed activation of endogenous gene by CRISPR-on an RNA-guided transcriptional activator system. Cell Res. 2013;23(10):1163–1171.
   PubMed Web of Science ®Google Scholar
• Mali P, Aach J, Stranges PB, et al. Cas9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol. 2013;31(9):833–838.
   PubMed Web of Science ®Google Scholar
• Maeder ML, Linder SJ, Cascio VM, Fu Y, Ho QH, Joung JK. CRISPR RNA-guided activation of endogenous human genes. Nat Methods. 2013;10(10):977–979.
   PubMed Web of Science ®Google Scholar
• Lin S, Ewen-Campen B, Ni X, Housden BE, Perrimon N. In vivo transcriptional activation using CRISPR/Cas9 in Drosophila. Genetics. 2015;201(2):433–442.
   Web of Science ®Google Scholar
• Cashman NR, Durham HD, Blusztajn JK, et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn. 1992;194(3):209–221.
   PubMed Web of Science ®Google Scholar
• Kaplan A, Spiller KJ, Towne C, et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron. 2014;81(2):333–345.
   PubMed Web of Science ®Google Scholar
• Flenniken AM, Williams BR. Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice. Genes Dev. 1990;4(7):1094–1106.
   Web of Science ®Google Scholar
• De Clerek YA, Darville MI, Eeckhout Y, Rousseau GG. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-1 (TIMP2). Gene. 1994;139:185–191.
   Web of Science ®Google Scholar
• Sun Y, Hegamyer G, Kim H, et al. Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. J Biol Chem. 1995;270(33):19312–19319.
   Web of Science ®Google Scholar
• Seipel K, Georgiev O, Schaffner W. A minimal transcription activation domain consisting of a specific array of aspartic acid and leucine residues. Biol Chem Hoppe-Seyler. 1994;375(7):463–470.
   Web of Science ®Google Scholar
• Chavez A, Scheiman J, Vora S, et al. Highly efficient Cas9-mediated transcriptional programming. Nat Methods. 2015;12(4):326–328.
   PubMed Web of Science ®Google Scholar
• Sadowski I, Ma J, Triezenberg S, Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator. Nature. 1988;335(6190):563–564.
   Web of Science ®Google Scholar
• Konermann S, Brigham MD, Trevino AE, et al. Genome-scale transcriptional activation by an engineered CRISPR/Cas9 complex. Nature. 2015;517(7536):583–588.
   PubMed Web of Science ®Google Scholar
• Cambell CE, Flenniken AM, Skup D, Williams BR. Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J Biol Chem. 1991;266(11):7199–7206.
   Web of Science ®Google Scholar
• Sampieri CL, Nuttall RK, Young DA, Goldspink D, Clark IM, Edwards DR. Activation of p38 and JNK MAPK pathways abrogates requirement for new protein synthesis for phorbol ester mediated induction of select MMP and TIMP genes. Matrix Biol. 2008;27(2):128–138.
   Web of Science ®Google Scholar
• Clark IM, Swingler TE, Sampieri CL, Edwards DR. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol. 2008;40(6–7):1362–1378.
   PubMed Web of Science ®Google Scholar
• Barkal AA, Srinivasan S, Hashimoto T, Gifford DK, Sherwood RI. Cas9 functionally opens chromatin. PLoS One. 2016;11(3):e0152683.
   Web of Science ®Google Scholar
• Murphy G. Tissue inhibitors of metalloproteinases. Genome Biol. 2011;12(11):233.
   PubMed Web of Science ®Google Scholar
• Kim TK, Shiekhattar R. Architectural and functional commonalities between enhancers and promoters. Cell. 2015;162:948–959.
   PubMed Web of Science ®Google Scholar